AIF1 and breast carcinoma: Finally, AIF1 appears to participate in the resistance of breast cancer cells to cisplatin by enhancing the uptake of intracellular cisplatin out of the cell and inhibiting apoptosis via the activation of Bcl-2 and suppression of p53 and Bax [136].